Equity Overview
Price & Market Data
Price: $18.48
Daily Change: +$0.23 / 1.24%
Range: $18.23 - $18.60
Market Cap: $0
Volume: 47,835
Performance Metrics
1 Week: 13.50%
1 Month: -4.91%
3 Months: -20.59%
6 Months: -38.39%
1 Year: -26.87%
YTD: -23.11%
Details
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.